The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.
CP: Cell biology
F box leucin-rich repeat E3 ubiquitin ligase
FBXL6
mitochondria
protein quality control
ribosomal proteins
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
27 06 2023
27 06 2023
Historique:
received:
21
12
2022
revised:
03
04
2023
accepted:
15
05
2023
medline:
4
10
2023
pubmed:
2
6
2023
entrez:
2
6
2023
Statut:
ppublish
Résumé
In mammals, about 99% of mitochondrial proteins are synthesized in the cytosol as precursors that are subsequently imported into the organelle. The mitochondrial health and functions rely on an accurate quality control of these imported proteins. Here, we show that the E3 ubiquitin ligase F box/leucine-rich-repeat protein 6 (FBXL6) regulates the quality of cytosolically translated mitochondrial proteins. Indeed, we found that FBXL6 substrates are newly synthesized mitochondrial ribosomal proteins. This E3 binds to chaperones involved in the folding and trafficking of newly synthesized peptide and to ribosomal-associated quality control proteins. Deletion of these interacting partners is sufficient to hamper interactions between FBXL6 and its substrate. Furthermore, we show that cells lacking FBXL6 fail to degrade specifically mistranslated mitochondrial ribosomal proteins. Finally, showing the role of FBXL6-dependent mechanism, FBXL6-knockout (KO) cells display mitochondrial ribosomal protein aggregations, altered mitochondrial metabolism, and inhibited cell cycle in oxidative conditions.
Identifiants
pubmed: 37267103
pii: S2211-1247(23)00590-9
doi: 10.1016/j.celrep.2023.112579
pii:
doi:
Substances chimiques
Mitochondrial Proteins
0
Ribosomal Proteins
0
Ubiquitin-Protein Ligases
EC 2.3.2.27
FBXL6 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
112579Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.